Abused inhalants enhance GABA-mediated synaptic inhibition.
about
Chemical exposure and hearing lossHow addictive drugs disrupt presynaptic dopamine neurotransmissionPharmacological classification of the abuse-related discriminative stimulus effects of trichloroethylene vapor.Review of toluene action: clinical evidence, animal studies and molecular targets.Effects of the abused inhalant toluene on the mesolimbic dopamine system.Cadmium increases the sensitivity of adolescent female mice to nicotine-related behavioral deficitsThe abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex.Hydrocarbon toxicity: A review.GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vaporVolatile solvents as drugs of abuse: focus on the cortico-mesolimbic circuitry.The latest evidence in the neuroscience of solvent misuse: an article written for service providers.Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in management.Discriminative Stimulus Effects of Abused Inhalants.Differential Effects of Toluene and Ethanol on Dopaminergic Neurons of the Ventral Tegmental Area.Binge toluene exposure alters glutamate, glutamine and GABA in the adolescent rat brain as measured by proton magnetic resonance spectroscopyDeath due to acute tetrachloroethylene intoxication in a chronic abuser.Adolescent inhalant use and executive cognitive functioning.
P2860
Q24169893-BDEAA7D4-EF16-4B10-B0D7-A20454E0C23CQ24631269-D9252E43-CA7E-47B3-B69B-3122233B8D33Q34139521-2A8F4E4D-97DB-4014-9401-6E639C222919Q34413651-A1451E13-21DE-440B-9AA8-69D9745E5253Q34414366-F7F1FC17-0951-4C66-9539-F9140A369737Q34588641-48A7B36B-886C-47F5-959D-8A084B95F035Q34988464-952688E7-B68B-481F-BEEF-68D8AE58E34DQ35184102-B416E4FC-6000-4716-A251-6B2AD95DBF0AQ35670267-62D7C647-32E9-4621-8CDF-314DE6C6E4B1Q37309789-91B93398-6C83-430F-909D-2C829C706410Q37879128-12A53C79-9429-4377-8F28-7A5774C011CFQ38047216-1CF66E05-6EE4-4A89-91CC-C5261EC8969CQ38974696-6208CD22-F2D0-4FCE-827D-6F753234EC45Q41145672-C390BE8D-8884-4360-A062-95AF2EAC7DCBQ42711020-F9CAF44E-F40D-4E6C-8976-505D6C626C5CQ44303812-540364F9-3D99-48F1-A041-3C21E6AF728EQ45036655-C466D0C6-DD5B-4067-AA21-C35F3CC6525A
P2860
Abused inhalants enhance GABA-mediated synaptic inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abused inhalants enhance GABA-mediated synaptic inhibition.
@en
Abused inhalants enhance GABA-mediated synaptic inhibition.
@nl
type
label
Abused inhalants enhance GABA-mediated synaptic inhibition.
@en
Abused inhalants enhance GABA-mediated synaptic inhibition.
@nl
prefLabel
Abused inhalants enhance GABA-mediated synaptic inhibition.
@en
Abused inhalants enhance GABA-mediated synaptic inhibition.
@nl
P2860
P356
P1476
Abused inhalants enhance GABA-mediated synaptic inhibition.
@en
P2093
M Bruce MacIver
P2860
P2888
P304
P356
10.1038/NPP.2009.57
P407
P577
2009-06-03T00:00:00Z